Miranda, my own motive is to discuss the company only. Nothing more. By the way, have you heard of Pharmasafe (cancer treatment)? I thought GCN holders were to get priority rights for it on a potential ASX listing last year. Did it list? I not that Priority One which is independently valued at $250m plus was expected by GCN to list this month. Any news on the prospectus as I can't wait to read it, along with the report.
some facts, page-41
-
- There are more pages in this discussion • 183 more messages in this thread...
This thread is closed.
You may not reply to this discussion at this time.
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)